Isavuconazole

GPTKB entity

Statements (43)
Predicate Object
gptkbp:instanceOf antiviral drug
triazole antifungal
gptkbp:approvalYear 2015
gptkbp:approvedBy gptkb:FDA
gptkb:EMA
gptkbp:ATCCode J02AC11
gptkbp:brand gptkb:Cresemba
gptkbp:CASNumber 241479-67-4
gptkbp:category antifungal agents
triazoles
gptkbp:chemicalFormula C22H17F2N5O
gptkbp:contraindication strong CYP3A4 inducers
familial short QT syndrome
hypersensitivity to isavuconazole
gptkbp:developer gptkb:Astellas_Pharma
gptkb:Basilea_Pharmaceutica
gptkbp:drugInteraction gptkb:phenytoin
gptkb:rifampin
gptkb:clarithromycin
gptkb:ritonavir
gptkb:carbamazepine
gptkb:ketoconazole
gptkbp:eliminationHalfLife 130 hours
https://www.w3.org/2000/01/rdf-schema#label Isavuconazole
gptkbp:IUPACName (2R,3R)-3-[2-(2,5-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]-1,2,4-triazol-1-yl]methyl]benzene
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits fungal cytochrome P450 enzyme 14α-demethylase
gptkbp:metabolism liver
gptkbp:pregnancyCategory C (US)
gptkbp:prodrugOf isavuconazonium sulfate
gptkbp:proteinBinding 99%
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect nausea
vomiting
diarrhea
hypokalemia
increased liver enzymes
gptkbp:UNII 6MG7U6Q9ZT
gptkbp:usedFor gptkb:mucormycosis
gptkb:invasive_aspergillosis
gptkbp:bfsParent gptkb:242138-07-4
gptkbp:bfsLayer 6